ACTRN12609000096257已完成2 期
Assessment of the potential of nebulised frusemide to relieve dyspnoea in people with advanced heart failure
St Vincent's Hospital0 个研究点目标入组 32 人开始时间: 2009年2月11日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Chronic stable heart failure
- •New York Heart Association Class 2-3
排除标准
- •Acute decompensated heart failure
- •NYHA Class 1 or 4
- •Inability to provide informed consent
研究者
相似试验
招募中
3 期
comparison of effects of nebulised Frusemide and placebi in patients with acute dyspnea transmited by EMSacute dyspnea.DyspneaIRCT20171014036753N2Iran University of Medical Sciences150
已完成
4 期
Interaction between frusemide and allopurinol drug treatments in patients with goutgoutMusculoskeletal - Other muscular and skeletal disordersACTRN12609000529246isa Stamp125
已完成
不适用
The effect of fluoride containing chlorhexidine on the gingival healthdental plaqe,gingival inflamation,dental color change.IRCT2016110630744N1vice chancellor for research of Golestan University of Medical Sciences40
尚未招募
3 期
Effect of nebulised furosemide on breathlessness and cough in interstitial lung disease: a pilot studyInterstitial Lung DiseaseACTRN12619001032145Hunter New England Health12
撤回
不适用
Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.Renal Impairment After Cardiac SurgeryNCT00246675Melbourne Health